Abstract:Four series of new 3-nitro naphthalimides derivatives, 4(4a‒4f), 5(5a‒5i), 6(6a‒6e) and 7(7a‒7j), were designed and synthesized as antitumor agents. Methyl thiazolyl tetrazolium (MTT) screening assay results revealed that some compounds displayed effective in vitro antiproliferative activity on SMMC-7721, T24, SKOV-3, A549 and MGC-803 cancer cell lines in comparison with 5-fluorouracil (5-FU), mitonafide and amonafide. Nude mouse xenotransplantation model assay results indicated that compounds 6b and 7b exhibited good in vivo antiproliferative activity in MGC-803 xenografts in comparison with amonafide and cisplatin, suggesting that compounds 6b and 7b could be good candidates for antitumor agents. Gel electrophoresis assay indicated that DNA and Topo I were the potential targets of compounds 6b and 7b, and comet assay confirmed that compounds 6b and 7b could induce DNA damage, while the further study showed that the 6b- and 7b-induced DNA damage was accompanied by the upregulation of p-ATM, P-Chk2, Cdc25A and p-H2AX. Cell cycle arrest studies demonstrated that compounds 6b and 7b arrested the cell cycle at the S phase, accompanied by the upregulation of the expression levels of the antioncogene p21 and the down-regulation of the expression levels of cyclin E. Apoptosis assays indicated that compounds 6b and 7b caused the apoptosis of tumor cells along with the upregulation of the expression of Bax, caspase-3, caspase-9 and PARP and the downregulation of Bcl-2. These mechanistic studies suggested that compounds 6b and 7b exerted their antitumor activity by targeting to DNA, thereby inducing DNA damage and Topo I inhibition, and consequently causing S stage arrest and the induction of apoptosis.

Molecular design, chemical synthesis, and biological evaluation of '4-1' pentacyclic aryl/heteroaryl-imidazonaphthalimides.

Synthesis and Evaluation of 2-[2-(phenylthiomethyl)-1h-benzo[d] Imidazol-1-yl)acetohydrazide Derivatives As Antitumor Agents

5-Non-amino aromatic substituted naphthalimides as potential antitumor agents: Synthesis via Suzuki reaction, antiproliferative activity, and DNA-binding behavior.

Synthesis and Biological Evaluation of Novel Aromatic Imide-Polyamine Conjugates.

Oxo-heterocyclic fused naphthalimides as antitumor agents: synthesis and biological evaluation.

Synthesis, DNA Binding Properties and Bioactivity of Naphthalimide Poly(ethylene Imine) Conjugates

Synthesis, antitumor and DNA photocleaving activities of novel naphthalene carboxamides: effects of different thio-heterocyclic rings and aminoalkyl side chains

Novel naphthalimide-benzoic acid conjugates as potential apoptosis-inducing agents: design, synthesis, and biological activity.

Design, Synthesis and Cytotoxic Activities of Novel Hybrid Compounds Between 2-Phenylbenzofuran and Imidazole.

The Novel Anti-Tumor Agents of 4-Triazol-1,8-naphthalimides: Synthesis, Cytotoxicity, DNA Intercalation and Photocleavage.

Design, Synthesis, and Antitumor Evaluation of Morpholine Substituted Bisnaphthalimides As DNA Targeting Agents.

Design, Synthesis, and Antitumor Evaluation of Novel Naphthalimide Derivatives

Naphthalimides and Analogues As Antitumor Agents:A Review on Molecular Design, Bioactivity and Mechanism of Action

Synthesis and Biological Evaluation of Novel 2-Arylvinyl-substituted Naphtho[2,3-D]imidazolium Halide Derivatives As Potent Antitumor Agents

Synthesis of new amonafide analogues via coupling reaction and their cytotoxic evaluation and DNA-binding studies.

Synthesis and Biological Evaluation of Some 1,8-Naphthalimide-acridinyl Hybrids

Design, Synthesis and Biological Evaluation of Novel Hybrid Compounds of Imidazole Scaffold-Based 2-Benzylbenzofuran As Potent Anticancer Agents

Unprecedented Synthesis, in Vitro and in Vivo Anti-Cancer Evaluation of Novel Triazolonaphthalimide Derivatives.

Design, synthesis and antitumor evaluation of new 1,8-naphthalimide derivatives targeting nuclear DNA

Design, Synthesis And Cytotoxic Activities Of Novel Hybrid Compounds Between Dihydrobenzofuran And Imidazole

[Synthesis and Antitumor Activity of Arylsubstituted Imidazolin-2-one Derivatives].